MENU
+Compare
XRAY
Stock ticker: NASDAQ
AS OF
Apr 24, 04:59 PM (EDT)
Price
$13.68
Change
+$0.40 (+3.01%)
Capitalization
6.69B

XRAY DENTSPLY SIRONA Forecast, Technical & Fundamental Analysis

Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies... Show more

XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XRAY with price predictions
Apr 23, 2025

XRAY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for XRAY turned positive on April 21, 2025. Looking at past instances where XRAY's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XRAY's RSI Indicator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 65 cases where XRAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 23, 2025. You may want to consider a long position or call options on XRAY as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XRAY advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

XRAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XRAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XRAY entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.032) is normal, around the industry mean (23.728). P/E Ratio (19.231) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (1.574) is also within normal values, averaging (5.667). Dividend Yield (0.018) settles around the average of (0.018) among similar stocks. P/S Ratio (1.725) is also within normal values, averaging (41.794).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XRAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XRAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
XRAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XRAY is expected to report earnings to fall 31.00% to 30 cents per share on May 08

DENTSPLY SIRONA XRAY Stock Earnings Reports
Q1'25
Est.
$0.30
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
Q1'24
Est.
$0.42
The last earnings report on February 27 showed earnings per share of 43 cents, beating the estimate of 43 cents. With 1.00M shares outstanding, the current market capitalization sits at 6.69B.
A.I.Advisor
published Dividends

XRAY paid dividends on April 11, 2025

DENTSPLY SIRONA XRAY Stock Dividends
А dividend of $0.16 per share was paid with a record date of April 11, 2025, and an ex-dividend date of March 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

a global denal eqipment company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
13320 Ballantyne Corporate Place
Phone
+1 844 848-0137
Employees
15000
Web
https://www.dentsplysirona.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RSST20.100.40
+2.03%
Return Stacked® US Stocks & Mgd Futs ETF
PFN7.140.07
+0.99%
PIMCO Income Strategy Fund II
HYUP40.830.27
+0.67%
Xtrackers High Beta High Yield Bond ETF
DFSD47.34-0.02
-0.04%
Dimensional Short-Duration Fixed Inc ETF
PDBA35.87-0.09
-0.25%
Invesco Agriculture Cmdty Str No K-1ETF

XRAY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XRAY has been loosely correlated with NVST. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if XRAY jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRAY
1D Price
Change %
XRAY100%
+2.00%
NVST - XRAY
48%
Loosely correlated
+3.63%
HBIO - XRAY
47%
Loosely correlated
+0.97%
STE - XRAY
46%
Loosely correlated
+0.49%
ALGN - XRAY
43%
Loosely correlated
+1.93%
KIDS - XRAY
42%
Loosely correlated
+0.05%
More